PSTV
Plus Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.66 / 10
Outperform
Capital flow assessment yields 8.44/10, denoting exceptionally strong fund flow dynamics. Strengths in overall, block, Small, Medium, Large, and Extra-large trends confront pressures from no significant trends patterns, resulting in highly favorable liquidity outlook. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 3 research evaluations, supported by 4.88 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-22
InstitutionD. Boral Capital
Times predicted16
Historical Win Rate37.5%
What is the market sentiment for PSTV?
- PSTV holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.66/10 (Outperform).
